Transplant Genomics

Transplant Genomics is using molecular diagnostics to enhance transplant outcomes. The current model to monitor for graft rejection requires painful and expensive biopsies and the appearance of rejection symptoms that often don’t appear until significant organ damage has occurred. Transplant Genomics uses their proprietary non-invasive blood gene expression profiling to monitor transplant health. Their platforms, TRAC Kidney, TRAC Liver, TruGraf Kidney and TruGraf Liver are being used to detect early signs of graft injury, differentiate causes, and optimize therapy for kidney and liver transplants. Transplant Genomics is pioneering precision medicine to redefine transplant care standards and improve patient outcomes.

Jobs: